Retatrutide is still in Phase 3 trials, while Lilly says no regulator has approved the experimental obesity drug for human use amid growing black-market sales.
Set as Trusted Source
on Google Search
Retatrutide is still in Phase 3 trials, while Lilly says no regulator has approved the experimental obesity drug for human use amid growing black-market sales.
Adani said the experience was more important for what it had taught him about life, people and relationships.
The government holds a 49% stake in Vodafone Idea but says it does not take part in the telecom company’s daily management or business decisions.
Ola Electric has received revised timelines under the ACC PLI scheme, giving it more time to scale battery production and potentially unlock incentives through 2031.
ZEEL told SAT the Rs 3,143 crore warrant issue was time-sensitive and in investors' interest, while SEBI opposed the transaction during the market ban.
The telecom major reported a nearly 12% sequential rise in consolidated net profit for the June quarter.
Recalling the Hindenburg Research allegations and the subsequent DoJ case, Adani said the experience strengthened his faith in the rule of law and deepened his humility.
Standalone revenue reaches a record Rs 11,795 crore, while Ebitda more than doubles and margin expands to 8.1% in the June quarter.
On the broader question of barriers facing women's career progression in the corporate sector, the ministry's response was direct.
Chandrasekaran's Tata Sons remuneration rose nearly threefold from FY18 to FY26, driven by a sharp rise in commission.